Journal
NEUROBIOLOGY OF DISEASE
Volume 52, Issue -, Pages 229-236Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2012.12.009
Keywords
Inflammation; Multiple sclerosis; EAE; Synaptic plasticity; LTP; Hippocampus
Categories
Funding
- Bayer Schering
- Biogen-Dompe
- Biogen-Idec
- Merck-Serono
- Novartis
- Sanofi-Aventis
- Boehringer Ingelheim
- Eisai
- Lundbeck
- Sigma-Tau
- UCB Pharma
- Ricerca Corrente IRCCS
- Ricerca Finalizzata IRCCS
- European Community Grant REPLACES
- Italian Minister of Health
- AIFA (Agenzia Italiana del Farmaco)
- Fondazione Italiana Sclerosi Multipla (FISM) [2010/R/10, 2011/R/10]
- Ministero della Salute-Ricerca Finalizzata-Bando Giovani Ricercatori [GR-2010-2312924]
Ask authors/readers for more resources
The central nervous system (CNS) and the immune system are known to be engaged in an intense bidirectional crosstalk. In particular, the immune system has the potential to influence the induction of brain plastic phenomena and neuronal networks functioning. During direct CNS inflammation, as well as during systemic, peripheral, inflammation, the modulation exerted by neuroinflammatory mediators on synaptic plasticity might negatively influence brain neuronal networks functioning. The aim of the present study was to investigate, by using electro-physiological techniques, the ability of hippocampal excitatory synapses to undergo synaptic plasticity during the initial clinical phase of an experimental model of CNS (experimental autoimmune encephalomyelitis, EAE) as well as following a systemic inflammatory trigger. Moreover, we compared the morphologic, synaptic and molecular consequences of central neuroinflammation with those accompanying peripheral inflammation. Hippocampal long-term potentiation (LTP) has been studied by extracellular field potential recordings in the CA1 region. Immunohistochemistry was performed to investigate microglia activation. Western blot and ELISA assays have been performed to assess changes in the subunit composition of the synaptic glutamate NMDA receptor and the concentration of pro-inflammatory cytokines in the hippocampus. Significant microglial activation together with an impairment of CM LTP was present in the hippocampus of mice with central as well as peripheral inflammation. Interestingly, exclusively during EAE but not during systemic inflammation, the impairment of hippocampal LTP was paralleled by a selective reduction of the NMDA receptor NR2B subunit levels and a selective increase of interleukin-1 beta (IL1 beta) levels. Both central and peripheral inflammation-triggered mechanisms can activate CNS microglia and influence the function of CNS synapses. During direct CNS inflammation these events are accompanied by detectable changes in synaptic glutamate receptors subunit composition and in the levels of the pro-inflammatory cytokine IL1 beta. (C) 2013 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available